APA (7th ed.) Citation

Verhoest, P. R., Fonseca, K. R., Hou, X., Proulx-LaFrance, C., Corman, M., Helal, C. J., . . . Liras, S. (2012). Design and Discovery of 6‑[(3S,4S)‑4-Methyl-1-(pyrimidin-2-ylmethyl)pyrrolidin-3-yl]-1-(tetrahydro‑2H‑pyran-4-yl)-1,5-dihydro‑4H‑pyrazolo[3,4‑d]pyrimidin-4-one (PF-04447943), a Selective Brain Penetrant PDE9A Inhibitor for the Treatment of Cognitive Disorders. Journal of medicinal chemistry, 55(21), 9045-9054. https://doi.org/10.1021/jm3007799

Chicago Style (17th ed.) Citation

Verhoest, Patrick R., et al. "Design and Discovery of 6‑[(3S,4S)‑4-Methyl-1-(pyrimidin-2-ylmethyl)pyrrolidin-3-yl]-1-(tetrahydro‑2H‑pyran-4-yl)-1,5-dihydro‑4H‑pyrazolo[3,4‑d]pyrimidin-4-one (PF-04447943), a Selective Brain Penetrant PDE9A Inhibitor for the Treatment of Cognitive Disorders." Journal of Medicinal Chemistry 55, no. 21 (2012): 9045-9054. https://doi.org/10.1021/jm3007799.

MLA (9th ed.) Citation

Verhoest, Patrick R., et al. "Design and Discovery of 6‑[(3S,4S)‑4-Methyl-1-(pyrimidin-2-ylmethyl)pyrrolidin-3-yl]-1-(tetrahydro‑2H‑pyran-4-yl)-1,5-dihydro‑4H‑pyrazolo[3,4‑d]pyrimidin-4-one (PF-04447943), a Selective Brain Penetrant PDE9A Inhibitor for the Treatment of Cognitive Disorders." Journal of Medicinal Chemistry, vol. 55, no. 21, 2012, pp. 9045-9054, https://doi.org/10.1021/jm3007799.